STK11 and lung cancer: In serine/threonine kinase 11 (STK11)-deficient LUAD, YAP directly stimulates downstream effector surviving to promote malignant progression, and YAP overexpression in the KrasG12D lung cancer mouse model accelerates tumor progression (Zhang et al., 2015).